The procedure follows the basic principle of radioimmunoassay where there is competition between the radioactive and non-radioactive antigen for a fixed number of antibody binding sites.

The amount of (I-125)-labeled analyte bound to the antibody is inversely proportional to the concentration of unlabeled analyte present.

The separation of free and bound antigen is achieved by using a double antibody system.

Hey, it seems that you’re connected from United States.

For registration requirements in countries outside of European market, please contact regulatory.affairs@diasource.be.